| BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018 | ||||
| Theme: Rethinking the Next Big Things in Pharma Innovations | ||||
| Time: August 16-19, 2018 Place: Boston Marriott Cambridge, USA |
||||
| Scientific Program | ||||
| Stream 1 | Stream 2 | Stream 3 | Stream 4 | Stream 5 |
| Stream 3: Industrial Art Gallery -Arts in Billion Dollar Molecules and Next Generation Therapy |
Substream 3-1: Improved Linear Drug Discovery on Selected Current Drug Targets Substream 3-6: Clinical Trial Gateway and Translational Convergence |
| Substream 3-6: Clinical Trial Gateway and Translational Convergence |
|||
|
Session 3601: Breakthroughs in Clinical Trials & Outsourcing and Integrative Services Day 2: Morning, Friday, August 17, 2018 Place: Enterprise Room, 3rd Floor 10:10-11:45 |
|||
| Chair: Dr. Greg Miller, Senior Data Scientist, BERG, USA | |||
| Time | FaceOn | Speeches and Speakers | |
| 10:10-10:05 | Chair's Introduction | ||
| 10:05-10:25 |  |
Title: Drug Resistant HCC and Approaches to Address and Overcome This in the Clinic Dr. Michael R. Briggs, Woodland Pharmaceuticals LLC; Tufts Cummings School of Veterinary Medicine, USA |
|
| 10:25-10:45 |  |
Title: Artificial Intelligence for De novo Biomarker Discovery in Clinical Trials Dr. Greg Miller, Senior Data Scientist, BERG, USA |
|
| 10:45-11:05 |  |
Title: Dose Recommendations of a Phase III Pivotal Clinical Study Dr. Naitee Ting, Director, Department of Biostatistics & Data Sciences, Boehringer-Ingelheim Pharmaceuticals Inc., USA |
|
| 11:05-11:25 |  |
Title: The Effective Outsourcing Process and Strategy: Evaluating Costs, Benefit, Risks and Rewards of Drug Development Outsourcing Strategies Dr. Lidia Cappellina, Head of R&D Outsourcing Management, Chiesi Group, Italy |
|
| 11:25-11:45 |  |
Title: Effective Approach for Site Selection Dr. Vladimir Shnaydman, President, ORBee Consulting, USA |
|
| 12:00-13:00 | Lunch | ||
|
Session 3602: Pharmacovigilance, Drug Safety and Risk Management Day 3: Morning, Saturday, August 18, 2018 Place: Enterprise Room, 3rd Floor 08:30-10:15 |
|||
| Chair: Dr. Vladimir Shnaydman, President, ORBee Consulting, USA | |||
| Time | FaceOn | Speeches and Speakers | |
| 08:30-08:35 | Chair's Introduction | ||
| 08:35-09:00 | |
Title: How to Optimize Risk Mitigation Strategy for a Clinical Trial with Limited Budget? Dr. Vladimir Shnaydman, President, ORBee Consulting, USA |
|
| 09:00-09:25 |  |
Title: Pharma Tech Case Studies, What Went Wrong? – Regulatory Investigations Dr. P. G. Shrotriya, CEO, Elite Consultancy Services – Pharma Consultant; Director, Pharma Research, School of Pharmacy and Technology Management, SVKM's NMIMS University, India |
|
| 09:25-09:50 |  |
Title: Sources of Biases in Studies of Drugs Safety during Pregnancy Dr. Amalia Levy, Chair, Department of Public Health, Ben-Gurion University of the Negev, Israel |
|
| 09:50-10:15 |  |
Title: Preclinical Integrated Risk Assessment of Suicidal Ideation and Behavior Dr. Laszlo Urban, Executive Director, Novartis Institutes for BioMedical Research, USA |
|
| 10:15-10:30 | Coffee Break | ||
|
Session 3603: National New Drug R & D Policy and Market Trend Day 3: Afternoon, Saturday, August 18, 2018 Place: Discovery Room, 3rd Floor 13:30-14:55 |
|||
| Chair: Dr. Niclas Nilsson, Head of RD Open Innovation, LEO Pharma A/S, Denmark | |||
| Time | FaceOn | Speeches and Speakers | |
| 13:30-13:35 | Chair's Introduction | ||
| 13:35-13:55 |  |
Title: Implementing Open Innovation 2.0 in the Pharmaceutical Drug Research Dr. Niclas Nilsson, Head of Open Innovation, Research, LEO Pharma, Denmark |
|
| 13:55-14:15 |  |
Title: Research, Breakthroughs, and Reach-through Royalties Dr. Jason Bryan, Shareholder, Polsinelli, USA |
|
| 14:15-14:35 |  |
Title: Patent Portfolio Development Strategies for Drug Discovery Dr. Tara Nealey, Shareholder, Vice Chair Biotechnology & Life Sciences Patent Practice, Polsinelli PC, USA |
|
| 14:35-14:55 |  |
Title: The Patent Game: Patent Strategies for Pharmaceutical and Med-Tech Companies Dr. Vance V. VanDrake, III, Partner, Ulmer & Berne LLP, USA |
|
| 14:55-15:10 | Coffee Break | ||
© 2003-2018 All rights reserved by BITeomics Inc. |